Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.40
-0.29 (-4.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.42
+0.02 (0.31%)
After-hours: Dec 5, 2025, 7:41 PM EST
Immuneering Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 413 | 68 | 215 | 128 | 426 | - | |
| Market Cap Growth | 552.40% | -68.25% | 67.99% | -69.91% | - | - | |
| Enterprise Value | 190 | 22 | 122 | 16 | 267 | - | |
| Last Close Price | 6.40 | 2.20 | 7.35 | 4.85 | 16.17 | - | |
| PS Ratio | - | - | - | 404.05 | 204.62 | - | |
| PB Ratio | 1.78 | 1.65 | 2.38 | 1.17 | 2.73 | - | |
| P/TBV Ratio | 1.87 | 1.99 | 2.58 | 1.25 | 2.86 | - | |
| EV/Sales Ratio | - | - | - | 49.59 | 128.17 | - | |
| Debt / Equity Ratio | 0.02 | 0.10 | 0.05 | 0.04 | 0.03 | 0.02 | |
| Asset Turnover | - | - | - | 0.00 | 0.02 | 0.09 | |
| Quick Ratio | 23.84 | 4.82 | 10.92 | 13.10 | 26.53 | 16.66 | |
| Current Ratio | 24.00 | 5.28 | 11.36 | 13.50 | 27.04 | 16.73 | |
| Return on Equity (ROE) | -43.75% | -92.51% | -53.36% | -38.00% | -35.00% | -74.56% | |
| Return on Assets (ROA) | -25.91% | -51.57% | -32.46% | -22.38% | -20.65% | -40.66% | |
| Return on Capital (ROIC) | -27.30% | -56.97% | -34.81% | -23.43% | -21.44% | -42.85% | |
| Return on Capital Employed (ROCE) | -27.70% | -141.70% | -61.70% | -45.30% | -21.00% | -47.20% | |
| Earnings Yield | -15.12% | -89.35% | -24.86% | -39.44% | -7.88% | - | |
| FCF Yield | -12.11% | -80.64% | -22.92% | -35.02% | -7.26% | - | |
| Buyback Yield / Dilution | -20.43% | -5.51% | -7.69% | -93.84% | -175.00% | 0.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.